CTLLABHealthcare Service Provider
Clinitech Laboratory Ltd — PE Ratio & Valuation Analysis
₹35.00
-6.23%
Current P/E21.07xPrice to earnings
Industry P/E39.28xSector average
4Y Avg P/E48.5x56.6% below avg
✅
46.4% Discount to Industry
CTLLAB P/E 21.07x vs sector avg 39.28x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹1.63 | ₹79 | 48.5x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Clinitech Laboratory Ltd Valuation
Clinitech Laboratory Ltd (CTLLAB) currently trades at 21.07x earnings. The Healthcare Service Provider sector average PE is 39.28x. CTLLAB is trading at a discount to peers — may indicate relative value. Historically, CTLLAB has traded at an average PE of 48.5x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
5.49%
Dividend Yield
0.00%
More on Clinitech Laboratory Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.